Some heart medicines are not simply swallowed as ordinary tablets because delivery route is part of the chemistry problem. A drug must dissolve in the right environment, survive metabolism long enough to work, and reach its target in a useful form and concentration.
Use the PDF for classwork, homework or revision. It includes key ideas, activities, questions, an extend task and success-criteria proof.
A patient needs a medicine that must act reliably, but the drug is partly broken down during its first trip through the liver after being swallowed.
📚 Core Content
Drug solubility is a chemical balancing act. Blood plasma is aqueous, but cell membranes are largely lipid-like, so the same molecule may behave very differently in different parts of the body.
Polar functional groups and the ability to form hydrogen bonds usually improve solubility in water. Less polar hydrocarbon-rich regions generally favour interaction with lipid environments. This is why medicinal chemistry often involves compromise rather than an “ideal” single property.
Wrong: The mole is a measure of mass.
Right: The mole is a measure of amount of substance; one mole contains Avogadro's number of particles.
Medicinal chemists use heuristic rules to estimate whether a drug is likely to be suitable for oral delivery. One of the best-known is Lipinski's Rule of Five.
These are not absolute laws. They are guides that help chemists judge whether a molecule may struggle with oral absorption.
Sometimes a drug is deliberately designed not to be the final active form when swallowed. Instead, the body converts it into the active compound after administration.
A prodrug is an inactive or less active compound that is metabolised in vivo to the active drug. Examples named in the course include codeine → morphine and aspirin → salicylic acid.
First-pass metabolism refers to the metabolism of a drug in the gut wall and especially the liver after absorption from the digestive tract but before the drug reaches general circulation in full concentration. This can lower oral bioavailability because less active drug reaches the rest of the body unchanged.
An orally absorbed drug reaches the liver before the general circulation. If substantial metabolism happens there, less unchanged active drug reaches the rest of the body, lowering oral bioavailability.
Drug delivery systems are not interchangeable packaging choices. Each route is chosen because it suits particular solubility, stability or bioavailability constraints.
For example, a transdermal patch works best for drugs that can cross skin barriers effectively, while an intravenous formulation requires strong compatibility with aqueous delivery.
Some medicines are designed not to release all at once. Controlled-release formulations aim to deliver the active compound gradually over time.
Their chemical basis often involves coatings, diffusion barriers, or matrix materials that slow how quickly the drug dissolves or escapes into body fluids. The result can be more stable drug concentration over time and fewer doses needed.
📊 Data Interpretation
A strong Module 8 answer identifies the actual problem first: solubility, first-pass metabolism, membrane crossing, or release rate. Only then does it choose the delivery system.
🧠 Activities
1 A drug has several -OH groups and multiple hydrogen-bonding sites.
2 A drug has a large hydrocarbon region and very few polar groups.
3 Explain how “like dissolves like” helps predict whether a drug formulation will need help dissolving in blood plasma.
1 A drug is effective, but only a small fraction reaches circulation after being swallowed because of liver metabolism.
2 A medicine needs to be delivered steadily for many hours rather than in one sharp burst.
3 A compound is designed to be converted in the body into the active drug.
1. Which statement best applies the principle “like dissolves like”?
2. Which set of conditions matches Lipinski's Rule of Five most closely?
3. What is first-pass metabolism?
What is NOT first-pass metabolism?
4. Why might a transdermal patch be chosen instead of an oral tablet?
5. Which statement best describes a prodrug?
1. Explain how polarity and hydrogen bonding influence the solubility of a drug in aqueous plasma compared with lipid membranes. 4 marks
2. Explain first-pass metabolism and analyse how it affects oral drug bioavailability. 5 marks
3. Evaluate the most suitable delivery strategy for a heart medicine that is strongly affected by first-pass metabolism and needs a steady therapeutic concentration. In your answer, compare an oral tablet with at least one alternative route or formulation. 5 marks
Return to the opening heart-medicine scenario and tighten your answer using delivery-system chemistry.
1. This suggests stronger aqueous solubility because multiple -OH groups and hydrogen-bonding sites increase polarity and interaction with water.
2. This suggests stronger lipid affinity and weaker aqueous solubility because the large hydrocarbon region is relatively non-polar.
3. Like dissolves like means polar drugs dissolve more easily in polar plasma, while less polar drugs may need formulation support if aqueous dissolution is poor.
1. A non-oral route such as transdermal or intravenous may be better because it can reduce or avoid first-pass metabolism.
2. A controlled-release formulation is suitable because it releases drug more gradually and helps maintain a steadier concentration.
3. This is a prodrug. Codeine converting to morphine is a named example, and the design can help optimise delivery or activation.
1. B — polar drugs generally dissolve more easily in aqueous environments.
2. D — these are the Rule of Five guide values given in the course.
3. A — first-pass metabolism occurs before a swallowed drug fully reaches general circulation.
4. C — a patch can bypass first-pass metabolism and provide steadier delivery.
5. B — a prodrug is metabolised in vivo to the active drug.
Q1 (4 marks): Polar groups and hydrogen-bonding ability increase a drug's interaction with water, so they usually improve solubility in aqueous plasma. Less polar or more hydrocarbon-rich regions are more compatible with lipid environments such as membranes. This means a drug that is very polar may dissolve well in plasma but cross membranes less easily, while a less polar drug may interact better with membranes but dissolve less well in water.
Q2 (5 marks): First-pass metabolism is the metabolism of a drug in the gut wall and especially the liver after it is absorbed from the digestive tract but before it reaches full systemic circulation. This reduces oral bioavailability because some of the drug is converted to other forms before the rest of the body receives it. As a result, a swallowed dose may deliver less active drug than expected. The stronger the first-pass effect, the poorer the efficiency of oral delivery may become.
Q3 (5 marks): An ordinary oral tablet may be a poor choice because first-pass metabolism can reduce the amount of active drug reaching general circulation. If the medicine also needs a steady therapeutic concentration, a transdermal patch or controlled-release non-oral formulation may be more suitable. A transdermal route can reduce first-pass metabolism and provide slower, sustained delivery over time. An IV route can bypass first-pass metabolism completely, but it may be less practical for routine long-term dosing. Overall, for a medicine needing both reduced first-pass loss and sustained delivery, a transdermal or controlled-release alternative is often more suitable than a standard oral tablet.
Solubility, Polarity & Drug Delivery
Tick when you've finished the activities and checked your answers.